Verve Therapeutics Statistics
Total Valuation
Readen Holding has a market cap or net worth of 16.24 million. The enterprise value is 18.95 million.
Market Cap | 16.24M |
Enterprise Value | 18.95M |
Important Dates
The last earnings date was Wednesday, July 30, 2025.
Earnings Date | Jul 30, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Readen Holding has 359.58 million shares outstanding. The number of shares has increased by 0.27% in one year.
Current Share Class | 359.58M |
Shares Outstanding | 359.58M |
Shares Change (YoY) | +0.27% |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | n/a |
Valuation Ratios
The trailing PE ratio is 27.43.
PE Ratio | 27.43 |
Forward PE | n/a |
PS Ratio | 4.51 |
PB Ratio | 1.66 |
P/TBV Ratio | 2.22 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | 32.00 |
EV / Sales | 5.26 |
EV / EBITDA | n/a |
EV / EBIT | 26.57 |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.17, with a Debt / Equity ratio of 0.28.
Current Ratio | 1.17 |
Quick Ratio | 0.83 |
Debt / Equity | 0.28 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | 4.23 |
Financial Efficiency
Return on equity (ROE) is 6.17% and return on invested capital (ROIC) is 3.42%.
Return on Equity (ROE) | 6.17% |
Return on Assets (ROA) | 3.17% |
Return on Invested Capital (ROIC) | 3.42% |
Return on Capital Employed (ROCE) | 6.00% |
Revenue Per Employee | 360,165 |
Profits Per Employee | 59,200 |
Employee Count | 10 |
Asset Turnover | 0.26 |
Inventory Turnover | 32.72 |
Taxes
Income Tax | -109,112 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +201.00% in the last 52 weeks. The beta is -0.05, so Readen Holding's price volatility has been lower than the market average.
Beta (5Y) | -0.05 |
52-Week Price Change | +201.00% |
50-Day Moving Average | 0.04 |
200-Day Moving Average | 0.03 |
Relative Strength Index (RSI) | 52.87 |
Average Volume (20 Days) | 7,202 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 0.74 |
Income Statement
In the last 12 months, Readen Holding had revenue of 3.60 million and earned 592,001 in profits. Earnings per share was 0.00.
Revenue | 3.60M |
Gross Profit | 780,218 |
Operating Income | 712,947 |
Pretax Income | 482,889 |
Net Income | 592,001 |
EBITDA | n/a |
EBIT | 712,947 |
Earnings Per Share (EPS) | 0.00 |
Balance Sheet
The company has 17,199 in cash and 2.73 million in debt, giving a net cash position of -2.71 million or -0.01 per share.
Cash & Cash Equivalents | 17,199 |
Total Debt | 2.73M |
Net Cash | -2.71M |
Net Cash Per Share | -0.01 |
Equity (Book Value) | 9.79M |
Book Value Per Share | 0.03 |
Working Capital | 256,110 |
Cash Flow
Operating Cash Flow | -8.13M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 21.66%, with operating and profit margins of 19.80% and 16.44%.
Gross Margin | 21.66% |
Operating Margin | 19.80% |
Pretax Margin | 13.41% |
Profit Margin | 16.44% |
EBITDA Margin | n/a |
EBIT Margin | 19.80% |
FCF Margin | n/a |
Dividends & Yields
Readen Holding does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -0.27% |
Shareholder Yield | n/a |
Earnings Yield | 3.65% |
FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | |
Lynch Upside | |
Graham Number | |
Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Readen Holding has an Altman Z-Score of 2.38 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 2.38 |
Piotroski F-Score | 5 |